Estrogen-receptor negative (triple-negative or HER2 - positive) breast cancer has a higher risk of early recurrence. This means within the first five years of diagnosis. Estrogen-receptor-positive tumors have a higher chance of later recurrence (after five years). Other risk factors of recurrence include larger tumors, lymph node involvement, younger age, more aggressive (higher grade) tumors, and type of initial treatment.